Understanding how medication adherence affects health in sarcoidosis patients
Medication Adherence and Clinical Outcomes in Sarcoidosis
This study is looking at how well people with sarcoidosis, especially in the African American community, stick to their medication and how that affects their health, with the goal of finding ways to help them manage their treatment better and improve their quality of life.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10888354 on NIH RePORTER |
What this research studies
This research investigates the relationship between medication adherence and clinical outcomes in patients with sarcoidosis, particularly focusing on the African American population, which is disproportionately affected by this condition. The study aims to identify barriers to medication adherence and develop self-management interventions that can improve patient knowledge and support adherence. By analyzing patient data and implementing behavioral strategies, the research seeks to enhance treatment outcomes and quality of life for individuals living with sarcoidosis.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with sarcoidosis, particularly those from the African American community.
Not a fit: Patients who do not have sarcoidosis or those who are not engaged in long-term treatment for the condition may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes and quality of life for patients with sarcoidosis through better medication adherence.
How similar studies have performed: Previous research has shown that self-management interventions can significantly improve clinical outcomes in other chronic respiratory diseases, suggesting a promising approach for this study.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Sharp, Michelle — Johns Hopkins University
- Study coordinator: Sharp, Michelle
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.